FEATURED
Glaukos reports phase 3 topline data on Epioxa for keratoconus

Findings will support an anticipated NDA submission for the second-generation iLink therapy by the end of 2024.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Research